Penn Medicine Provider
Dermatology
Emily Y. Chu, MD, PhD
4.9
(223)
Accepting new patients
Sees patients age 15 and up
Penn Dermatology Perelman

About me

  • Associate Professor of Dermatology at the Hospital of the University of Pennsylvania
  • Associate Professor of Dermatology in Pathology and Laboratory Medicine

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Memorial Sloan-Kettering Cancer Center
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

223 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
efficient and thorough
April 2025
5.0
5.0
have confidence in her
March 2025
5.0
5.0
very compassionate
March 2025
5.0
5.0
dr chu is very approachable and professional

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Chu is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Nguyen, C.V., Gaddis, K.J., Stephens, M.R., Seykora, J.T., Chu, E.Y. An intra-patient concordance study of mismatch repair protein immunohistochemical staining patterns in patients with Muir-Torre syndrome. , JAMA Dermatology , 156(6): 2020,1-5


Ma, S.A, O’Day, C.P., Dentchev, T., Takeshita, J., Ridky. T.W., Seykora, J.T., Chu, E.Y. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms. , Journal of Cutaneous Pathology , 46(5): 2019,310-316


Parekh, V., Sobanko, J., Miller, C.J., Karakousis, G., Xu, W., Letrero, R., Elenitsas, R., Amaravadi, R., Schuchter, L.M., Nathanson, K., Xu, X., Elder, D.E., Wilson, M.A., Chu, E.Y. NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions arising in advanced melanoma patients treated with vemurafenib. , Journal of Cutaneous Pathology, 46(3): 2019,190-194


Wang, L.L., Patel, G., Chiesa Fuxench, Z.C., McGettigan, S., Schuchter, L.M., Mitchell, T.C., Ming, M.E., Chu, E.Y. Timing of onset of adverse cutaneous reactions associated with programmed cell death-1 inhibitors. , JAMA Dermatology, 154(9): 2018,1057-1061


Xu, M., Horrell, J., Snitow, M., Cui, J., Gochnauer, H., Syrett, C., Kallish, S., Seykora, J.T., Liu, F., Gaillard, D., Katz, J., Kaestner, K., Levin, B., Mansfield, C., Douglas, J., Cowart, B., Tordoff, M., Liu, F., Zhu, X., Barlow, L., Rubin, A., McGrath, J., Morrisey, E., Chu, E.Y., & Millar, S.E. WNT10A mutation causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation. , Nature Communications, 8(15397): 2017


Marek Andrew J, Ming Michael E, Bartlett Edmund K, Karakousis Giorgos C, Chu Emily Y Acral Lentiginous Histologic Subtype and Sentinel Lymph Node Positivity in Thin Melanoma. , JAMA Dermatology, 152(7): 2016,836-7


Chu, E.Y., Wanat, K.A., Miller, C.J., Amaravadi, R.K., Fecher, L.A., Brose, M.S., McGettigan, S., Giles, L.R., Schuchter, L.M., Seykora, J.T., Rosenbach, M. Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study , J Am Acad Dermatol, 67(6): 2012,1265-1272


Chu, E. Y., Freeman, A. F., Jing, H., Cowen, E. W., Davis, J., Su, H. C., Holland, S. M., Turner, M. L. Cutaneous manifestations of DOCK8 deficiency syndrome. , Arch Dermatol, 148(1): 2012,79-84


Chu, E.Y., Hens, J., Andl, T., Kairo, A., Yamaguchi, T.P., Brisken, C., Glick, A., Wysolmerski, J.J., Millar, S.E. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis , Development, 131(19): 2004,4819-29


Li, F., Ambrosini, G., Chu, E.Y., Plescia, J., Tognin, S., Marchisio, P.C., Altieri, D.C. Control of apoptosis and mitotic spindle checkpoint by survivin , Nature, 396(6711): 1998,580-4